Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose - Clemmons, D R; Moses, A C; Sommer, A (Growth Hormone & IGF Research, 2005)
et al.